Skip to content
Finance Investment, Medical Health Aged Care

Nutritional Growth Solutions (ASX:NGS) – Walmart Awards Additional Stores, CVS and iHerb Onboarding

Nutritional Growth Solutions Ltd (ASX:NGS) 2 mins read

Nutritional Growth Solutions Ltd (ASX:NGS) (“NGS”, or the “Company”), a leading global nutrition company dedicated to creating clinically proven products that support growth and development in children, is thrilled to announce significant advancements in its retail partnerships.

Key Highlights:

  • Walmart Expansion: NGS is proud to announce that its innovative product, Happy Tummies®, will now be available in 850 Walmart stores. This marks an increase of 55 stores from the initially expected 795, showcasing Walmart's growing confidence in the product (refer ASX Release – 18 September 2023).

  • CVS Partnership: The onboarding process with CVS has been successfully completed. Customers can anticipate seeing Happy Tummies® on CVS shelves by Q1 CY2024, prominently featured in a multi-brand “Children’s Nutrition” display.

  • iHerb Collaboration: NGS has finalized its onboarding with iHerb. An initial order valued at approximately US$10,000 has been placed, with Healthy Heights® products set to be available on iHerb’s marketplaces in Q4 CY2023. Furthermore, iHerb fulfillment centers will stock three cases of each item in NGS’ portfolio. Initial sales will be closely monitored to determine forecasted sales velocity and guide replenishment strategies.

  • Strategic Restructuring: As part of its ongoing commitment to excellence, NGS continues to streamline its operations through strategic restructuring. The Company is excited to welcome Rob Valerio as its new fractional CFO based in the US.

  • Brand Expansion: The expansion of the Healthy Heights® brand into additional markets is underway. This move is anticipated to foster further discussions and collaborations with additional retailers, amplifying the brand's reach and impact.

NGS CEO, Stephen Turner, Commented: “We are thrilled to see Walmart’s strong commitment to NGS by expanding the distribution of our new product, Happy Tummies®, to a total of 850 stores. This is a significant milestone for NGS and a testament to the increasing demand for our products, as we continue to see Healthy Heights® grow along with Walmart’s help.” 

“Additionally, NGS recently successfully completed the onboarding process with both iHerb and CVS, representing strong steps towards a broader market reach. Products will be delivered to iHerb’s distribution centre and become available on iHerb’s marketplaces from Q4 CY2023. We are expecting sales with iHerb to be significant and will utilize tactics and strategies to push for a goal of $1 million over 12 months.” 

“We’re also pleased to welcome Rob Valerio as our fractional CFO, further strengthening our team on the ground in the US. NGS would like to express its sincere appreciation to Yossi Nizhar for his valuable contributions to date.” 

“I would like to thank shareholders for their support to date, and NGS looks forward to providing further updates before the end of the year.” 


About us:

Nutritional Growth Solutions is a global nutritional health company focused on the well-being of children. NGS develops, produces and sells clinically tested nutritional supplement formulae for children following 20 years of medical research into pediatric nutrition at Schneider Children’s Medical Centre, Israel’s largest pediatric hospital. The nutritional supplements market has experienced tremendous growth in recent years, but most attention has been focused on adult users and children under three years of age. The three to twelve-year-old consumers represent a larger market opportunity and NGS is highly differentiated from its competitors with clinically tested products and an expanding product portfolio to capture this market opportunity. 


Contact details:

Chloe Hayes

[email protected]

Media

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Finance Investment
  • 11/07/2025
  • 10:04
Chartered Accountants ANZ

NEW CA FOUNDATIONS OPENS THE DOOR TO MORE CHARTERED ACCOUNTANT STUDENTS

11 July 2025 Chartered Accountants Australia and New Zealand (CA ANZ) has officially launched its new CA Foundations program, designed to make the Chartered Accountant designation more accessible to a broader, more diverse range of aspiring professionals and help address the profession’s talent shortage. Simon Hann, Group Executive Education and Marketing, said the new program reflects CA ANZ’s commitment to evolving pathways to the world class CA Program that meet the needs of the profession and the community. “We know the profession is changing, and so are the people entering it. CA Foundations is about opening the door wider –…

  • Contains:
  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.